F573 for Injection for the Treatment of Liver Injury/Failure

Clinical trial NCT05689645 · RECRUITING

Trial details

NCT number: NCT05689645
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Liver Failure Acute-On-Chronic Liver Failure

Start date: 2023-03-24
Primary completion: 2026-09-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.